Biodistribution of a Bispecific Single-chain Diabody and Its Half-life Extended Derivatives

Site-Specific Polysialylation of an Antitumor Single-Chain Fv Fragment

(2009) A. Constantinou et al.   BIOCONJUGATE CHEMISTRY

Strategies to Extend Plasma Half-Lives of Recombinant Antibodies

(2009) Roland E. Kontermann   BIODRUGS

Therapeutic window of an EpCAM/CD3-specific BiTE antibody in mice is determined by a subpopulation of EpCAM-expressing lymphocytes that is absent in humans

(2008) Maria Amann et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

N-Glycosylation as Novel Strategy to Improve Pharmacokinetic Properties of Bispecific Single-chain Diabodies

(2008) Roland Stork et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology

(2008) B. M. Tijink et al.   MOLECULAR CANCER THERAPEUTICS

Engineering of a femtomolar affinity binding protein to human serum albumin

(2008) A. Jonsson et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody

(2008) R. Bargou et al.   SCIENCE

Mutational analysis of the interaction between albumin-binding domain from streptococcal protein G and human serum albumin

(2002) Martin Linhult et al.   PROTEIN SCIENCE